| NO gets a test ride on high-tech transporting nanodevices: A commentary on "Sustained-release nitric oxide from long-lived circulating nanoparticles". | |
| | |
MedLine Citation:
|
PMID: 20639121 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Vladimir R Muzykantov |
Publication Detail:
|
Type: Comment; Journal Article |
Journal Detail:
|
Title: Free radical biology & medicine Volume: 49 ISSN: 1873-4596 ISO Abbreviation: Free Radic. Biol. Med. Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-19 Completed Date: 2011-01-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8709159 Medline TA: Free Radic Biol Med Country: United States |
Other Details:
|
Languages: eng Pagination: 528-9 Citation Subset: IM |
Affiliation:
|
Institute for Translational Medicine and Therapeutics, and Department of Pharmacology, University of Pennsylvania, Philadelphia, PA 19104, USA. muzykant@mail.med.upenn.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Drug Delivery Systems Nanoparticles / chemistry* Nanotechnology / instrumentation, methods* Nitric Oxide* / chemistry, metabolism, pharmacokinetics |
| Chemical | |
Reg. No./Substance:
|
10102-43-9/Nitric Oxide |
| Comments/Corrections | |
Comment On:
|
Free Radic Biol Med. 2010 Aug 15;49(4):530-8
[PMID:
20460149
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Multi-mechanisms are involved in reactive oxygen species regulation of mTORC1 signaling.
Next Document: Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism.